Quipt Home Medical Corp.
QIPT
$2.43
-$0.075-3.00%
| Weiss Ratings | QIPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | QIPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | QIPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.60 | |||
| Price History | QIPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.04% | |||
| 30-Day Total Return | -23.74% | |||
| 60-Day Total Return | -14.01% | |||
| 90-Day Total Return | -10.52% | |||
| Year to Date Total Return | -16.38% | |||
| 1-Year Total Return | -41.64% | |||
| 2-Year Total Return | -62.81% | |||
| 3-Year Total Return | -47.40% | |||
| 5-Year Total Return | 56.29% | |||
| 52-Week High % Change | -43.57% | |||
| 52-Week Low % Change | 8.52% | |||
| Price | QIPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $4.43 | |||
| 52-Week Low Price | $2.30 | |||
| 52-Week Low Price (Date) | Dec 19, 2024 | |||
| 52-Week High Price (Date) | Mar 28, 2024 | |||
| Valuation | QIPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 107.45M | |||
| Enterprise Value | 192.52M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.17 | |||
| Earnings Per Share Growth | 42.10% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.44 | |||
| Price/Book (Q) | 1.01 | |||
| Enterprise Value/Revenue (TTM) | 0.79 | |||
| Price | $2.43 | |||
| Enterprise Value/EBITDA (TTM) | 4.36 | |||
| Enterprise Value/EBIT | 208.81 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | QIPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 43.09M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | QIPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 859 878 2220 | |||
| Address | 1019 Town Drive Wilder, KY 41076 | |||
| Website | quipthomemedical.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | QIPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 0.37% | |||
| Profit Margin | -2.85% | |||
| Management Effectiveness | QIPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 0.24% | |||
| Return on Equity | -- | |||
| Income Statement | QIPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 244.72M | |||
| Total Revenue (TTM) | 244.72M | |||
| Revenue Per Share | $5.68 | |||
| Gross Profit (TTM) | 175.93M | |||
| EBITDA (TTM) | 44.15M | |||
| EBIT (TTM) | 922.00K | |||
| Net Income (TTM) | -6.99M | |||
| Net Income Avl. to Common (TTM) | -6.99M | |||
| Total Revenue Growth (Q YOY) | -1.90% | |||
| Earnings Growth (Q YOY) | 27.15% | |||
| EPS Diluted (TTM) | -0.17 | |||
| EPS Diluted Growth (Q YOY) | 25.00% | |||
| Balance Sheet | QIPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 15.45M | |||
| Cash Per Share (Q) | $0.36 | |||
| Total Current Assets (Q) | 69.66M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 106.31M | |||
| Current Ratio (Q) | 1.220 | |||
| Book Value Per Share (Q) | $2.47 | |||
| Total Assets (Q) | 242.82M | |||
| Total Current Liabilities (Q) | 57.08M | |||
| Total Debt (Q) | 100.81M | |||
| Total Liabilities (Q) | 136.50M | |||
| Total Common Equity (Q) | 106.31M | |||
| Cash Flow | QIPT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -12.33M | |||
| Cash from Financing (TTM) | -22.38M | |||
| Net Change in Cash (TTM) | -2.88M | |||
| Levered Free Cash Flow (TTM) | 29.30M | |||
| Cash from Operations (TTM) | 32.95M | |||
